Comparing Efficacy and Safety of TJO-083 in Dry Eye Diseases Patients

PHASE3CompletedINTERVENTIONAL

Enrollment

271

Participants

Timeline

Start Date

July 14, 2023

Primary Completion Date

May 22, 2024

Study Completion Date

July 3, 2024

Conditions

Dry EyeDry Eye Syndromes

Interventions

DRUG

TJO-083

Diquafosol ophthalmic sodium solution, 1 drop 3 times a day

DRUG

Diquafosol ophthalmic sodium solution 3%

Diquafosol ophthalmic sodium solution, 1 drop 6 times a day

Trial Locations (1)

Taejoon Pharmaceutical Co., Ltd., Seoul

All Listed Sponsors

lead

Taejoon Pharmaceutical Co., Ltd.

INDUSTRY